Please login to the form below

Not currently logged in
Email:
Password:

Dr Alan Joslyn becomes president and CEO of Oragenics

He will also serve on the company’s board of directors

Florida-based Oragenics has appointed Dr Alan Joslyn as its new president, chief executive officer and member of the board of directors.

Dr Joslyn was a founding partner of Lazarus Pharmaceuticals, and has served as chief executive officer at both Edusa Pharmaceuticals and Sentinella Pharmaceuticals.

Prior to this, he worked at Penwest Pharmaceuticals as the senior vice president of research and development, and has held senior drug development positions within Johnson & Johnson.

Dr Frederick Telling, chairman of Oragenics, said: “As Oragenics opens this new chapter, the board and I are confident that Dr Joslyn is the right person to lead the company forward.

“He has proven ability to create strategic clarity, drive innovation and ensure disciplined execution as well as a depth of experience from serving a large pharmaceutical company and smaller research oriented companies, with particular experience in gastrointestinal disease and lantibiotics.

“We believe that his passion for technology will help ensure that Oragenics continues to strive to deliver innovations that have a positive impact on people's lives.”

17th June 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
FCB Halesway

A Eureka moment! A converted dairy in the Hampshire countryside back in 1993 saw the inception of Halesway as a...

Latest intelligence

women
Advancing women in healthcare
Fostering the next generation of leaders...
The Challenges Of UX In Healthcare: Technology To Change Lives
Blue Latitude Health Director and Head of Customer Experience Elisa Del Galdo explores the latest digital healthcare trends and reveals the innovations changing the sector today....
It’s all about patient outcomes… right?
Lessons from history: a design thinking perspective...

Infographics